> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Mull Leqembi Confirmatory Study
- URL: https://www.fdaweb.com/panel-to-mull-leqembi-confirmatory-study/
- Published: 2023-04-10T12:00:00.000Z
- Updated: 2026-09-14T18:24:40.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5154171

*Federal Register* notice: FDA has announced a 6/9 Peripheral and Central Nervous System Drugs Advisory Committee to review an Eisai supplemental BLA for Alzheimer’s drug Leqembi (lecanemab) solution for intravenous infusion. The submission includes a confirmatory study that seeks to convert the drug’s current accelerated approval to full approval. To view the notice, click [here](https://public-inspection.federalregister.gov/2023-07526.pdf?ref=fdaweb.com).